je.st
news
Naurex Announces Issuance Of New Patent For Novel Antidepressant GLYX-13
2013-07-31 08:38:27| drugdiscoveryonline News Articles
Naurex Inc., a clinical-stage company developing innovative treatments to address unmet needs in psychiatry and neurology, today announced issuance of a new U.S. patent for its lead compound, GLYX-13
Tags: patent
announces
issuance
antidepressant
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||